Nom du produit:3-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

IUPAC Name:3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

CAS:2304635-16-1
Formule moléculaire:C14H19BN2O2
Pureté:95%+
Numéro de catalogue:CM390453
Poids moléculaire:258.13

Unité d'emballage Stock disponible Prix($) Quantité
CM390453-100mg in stock ưưɅ
CM390453-250mg in stock ƦưƦ
CM390453-1g in stock ȬȬŴ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2304635-16-1
Formule moléculaire:C14H19BN2O2
Point de fusion:-
Code SMILES:CC1=NNC2=C1C(=CC=C2)B1OC(C)(C)C(C)(C)O1
Densité:
Numéro de catalogue:CM390453
Poids moléculaire:258.13
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Indazoles
Indazoles are a class of organic heterocyclic compounds, also known as 1,2-diazaindene and benzopyrazole. Indazole is a good bioisomer of phenol, which is more lipophilic than phenol and less prone to phase I and II metabolism. Indazole derivatives have a wide range of biological activities, and it has been confirmed that indazole compounds have anti-tumor, analgesic, anti-inflammatory and other drug activities. Anticancer is the most important application field of indazole drugs. Renal cell carcinoma, solid tumor, nausea and vomiting caused by chemotherapy and leukemia are the main indications of this structural backbone drug.

Related Products